NM_000719.7:c.1783G>A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_000719.7(CACNA1C):c.1783G>A(p.Val595Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,613,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V595V) has been classified as Likely benign.
Frequency
Consequence
NM_000719.7 missense
Scores
Clinical Significance
Conservation
Publications
- Timothy syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizuresInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- long QT syndromeInheritance: AD Classification: MODERATE Submitted by: ClinGen
- long QT syndrome 8Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- Brugada syndromeInheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
- Brugada syndrome 3Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- short QT syndromeInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNA1C | NM_000719.7 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | ENST00000399655.6 | NP_000710.5 | |
| CACNA1C | NM_001167623.2 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1C | ENST00000399603.6 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
| CACNA1C | ENST00000399655.6 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
| CACNA1C | ENST00000682544.1 | c.1873G>A | p.Val625Ile | missense_variant | Exon 13 of 50 | ENSP00000507184.1 | ||||
| CACNA1C | ENST00000406454.8 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 48 | 5 | ENSP00000385896.3 | |||
| CACNA1C | ENST00000399634.6 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | 5 | ENSP00000382542.2 | |||
| CACNA1C | ENST00000683824.1 | c.1948G>A | p.Val650Ile | missense_variant | Exon 14 of 48 | ENSP00000507867.1 | ||||
| CACNA1C | ENST00000347598.9 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 49 | 1 | ENSP00000266376.6 | |||
| CACNA1C | ENST00000344100.7 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | 1 | ENSP00000341092.3 | |||
| CACNA1C | ENST00000327702.12 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 48 | 1 | ENSP00000329877.7 | |||
| CACNA1C | ENST00000399617.6 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 48 | 5 | ENSP00000382526.1 | |||
| CACNA1C | ENST00000682462.1 | c.1873G>A | p.Val625Ile | missense_variant | Exon 13 of 47 | ENSP00000507105.1 | ||||
| CACNA1C | ENST00000683781.1 | c.1873G>A | p.Val625Ile | missense_variant | Exon 13 of 47 | ENSP00000507434.1 | ||||
| CACNA1C | ENST00000683840.1 | c.1873G>A | p.Val625Ile | missense_variant | Exon 13 of 47 | ENSP00000507612.1 | ||||
| CACNA1C | ENST00000683956.1 | c.1873G>A | p.Val625Ile | missense_variant | Exon 13 of 47 | ENSP00000506882.1 | ||||
| CACNA1C | ENST00000399638.5 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 48 | 1 | ENSP00000382547.1 | |||
| CACNA1C | ENST00000335762.10 | c.1858G>A | p.Val620Ile | missense_variant | Exon 14 of 48 | 5 | ENSP00000336982.5 | |||
| CACNA1C | ENST00000399606.5 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 48 | 1 | ENSP00000382515.1 | |||
| CACNA1C | ENST00000399621.5 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | 1 | ENSP00000382530.1 | |||
| CACNA1C | ENST00000399637.5 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | 1 | ENSP00000382546.1 | |||
| CACNA1C | ENST00000402845.7 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | 1 | ENSP00000385724.3 | |||
| CACNA1C | ENST00000399629.5 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | 1 | ENSP00000382537.1 | |||
| CACNA1C | ENST00000682336.1 | c.1858G>A | p.Val620Ile | missense_variant | Exon 14 of 47 | ENSP00000507898.1 | ||||
| CACNA1C | ENST00000399591.5 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 46 | 1 | ENSP00000382500.1 | |||
| CACNA1C | ENST00000399595.5 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 46 | 1 | ENSP00000382504.1 | |||
| CACNA1C | ENST00000399649.5 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 46 | 1 | ENSP00000382557.1 | |||
| CACNA1C | ENST00000399597.5 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | 1 | ENSP00000382506.1 | |||
| CACNA1C | ENST00000399601.5 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | 1 | ENSP00000382510.1 | |||
| CACNA1C | ENST00000399641.6 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | 1 | ENSP00000382549.1 | |||
| CACNA1C | ENST00000399644.5 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | 1 | ENSP00000382552.1 | |||
| CACNA1C | ENST00000682835.1 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 47 | ENSP00000507282.1 | ||||
| CACNA1C | ENST00000683482.1 | c.1774G>A | p.Val592Ile | missense_variant | Exon 13 of 47 | ENSP00000507169.1 | ||||
| CACNA1C | ENST00000682686.1 | c.1783G>A | p.Val595Ile | missense_variant | Exon 13 of 46 | ENSP00000507309.1 | ||||
| CACNA1C | ENST00000480911.6 | n.*390G>A | non_coding_transcript_exon_variant | Exon 11 of 27 | 5 | ENSP00000437936.2 | ||||
| CACNA1C | ENST00000480911.6 | n.*390G>A | 3_prime_UTR_variant | Exon 11 of 27 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152160Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000177 AC: 44AN: 249014 AF XY: 0.000148 show subpopulations
GnomAD4 exome AF: 0.000103 AC: 150AN: 1461386Hom.: 0 Cov.: 31 AF XY: 0.000102 AC XY: 74AN XY: 726944 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000177 AC: 27AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74444 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
CACNA1C-related disorder Uncertain:1
The CACNA1C c.1783G>A variant is predicted to result in the amino acid substitution p.Val595Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.088% of alleles in individuals of European (Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not provided Uncertain:1
Has not been previously published as pathogenic or benign to our knowledge; Reported in ClinVar as a variant of uncertain significance and a likely benign variant (ClinVar Variant ID 190611; Landrum et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function -
not specified Benign:1
- -
Long QT syndrome Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at